Ciitizen was a patient-centric health technology company dedicated to helping patients collect, organize, and share their medical records easily and securely. Their platform empowered individuals, especially those with complex conditions like cancer, to take control of their health journey by providing them with a comprehensive, usable digital copy of their health information. In September 2021, Ciitizen was acquired by Invitae (NYSE: NVTA), a medical genetics company, to integrate its patient-consented data capabilities into Invitae's platform. The ciitizen.com domain now directs to information about the Ciitizen network within Invitae. Invitae filed for Chapter 11 bankruptcy in February 2024, creating uncertainty for its assets, including the Ciitizen platform.
Served as the primary hub for research, development, product management, and administrative operations for Ciitizen's patient-centric health data platform.
Likely a modern tech office space typical of Silicon Valley, featuring open-plan areas for collaboration, meeting rooms, and contemporary amenities. Specific unique architectural details were not widely publicized.
Characterized by a strong patient-first mission, fostering innovation in health data accessibility. The culture was likely collaborative, fast-paced, and purpose-driven, typical of a startup environment aiming to empower patients.
The Palo Alto headquarters was the birthplace of Ciitizen's platform and the center of its strategic operations, driving its efforts to revolutionize how patients access and use their health information.
Prior to its acquisition by Invitae, Ciitizen primarily focused its operations and user base within the United States, offering its health record management services to American patients. While its platform was digital and potentially accessible with an internet connection, its direct support, regulatory compliance, and partnerships were U.S.-centric. Following the acquisition, its technology was intended to contribute to Invitae's broader, though now uncertain, global reach in genetic information services.
250 Cambridge Ave
Palo Alto
CA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Ciitizen' leadership includes:
Ciitizen has been backed by several prominent investors over the years, including:
Ciitizen was acquired by Invitae in September 2021 and ceased to operate as an independent entity. Therefore, there have been no executive new hires or exits specifically for 'Ciitizen' in the last 12 months. Key leadership transitioned to Invitae at the time of acquisition or moved on to other ventures prior to or around that period. Any subsequent changes involving former Ciitizen executives would be within the context of their roles at Invitae or other organizations.
Discover the tools Ciitizen uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its acquisition by Invitae and the subsequent discontinuation of its independent operations, Ciitizen likely utilized common email address formats typical for technology companies (e.g., combining first name, last name, or initials with @ciitizen.com). These email addresses are no longer expected to be active or monitored.
[first].[last]@ciitizen.com or [first_initial][last]@ciitizen.com
Format
jane.doe@ciitizen.com or jdoe@ciitizen.com
Example
0%
Success rate
Fierce Biotech • February 14, 2024
Invitae Corp., the genetic testing company that acquired Ciitizen in 2021, filed for Chapter 11 bankruptcy protection. The company plans to continue operations while seeking a sale of its assets, which creates uncertainty for the future of its various platforms and services, including the Ciitizen patient data network....more
MobiHealthNews • September 7, 2021
Invitae announced its acquisition of Ciitizen, a patient-centric health data company, for approximately $325 million in cash and stock. The acquisition was aimed at integrating Ciitizen's platform for collecting and structuring patient medical records into Invitae's genetic information services to improve personalized medicine and research....more
Ciitizen Blog (Archived/Referenced) • May 18, 2021
Ciitizen announced it had successfully completed its SOC 2 Type II audit, underscoring its commitment to data security and privacy for patient health information. This achievement highlighted the platform's robust security controls before its acquisition by Invitae later that year....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Ciitizen, are just a search away.